A drug development company specialized in proprietary cardiac targeting peptide platform technology, Vivasc Therapeutics is an early-stage, pre-clinical firm structured around enabling patients to recover from cardiac disease, The firm is addressing development and utilization of the proprietary Cardiac Targeting Peptide (CTP) platform technology to deliver various cargo exclusively to cardiomyocytes in a non-invasive manner. A drug development company specializing in proprietary cardiac targeting peptide platform technology.
